Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2012
03/14/2012EP2427215A1 Stable pharmaceutical compositions of peptide derivatized using an oxime linker
03/14/2012EP2427208A1 Fgf21 mutants and uses thereof
03/14/2012EP2427207A2 Fgf21 mutants and uses thereof
03/14/2012EP2427204A1 Melanocortin receptor binding conjugates
03/14/2012EP2427203A2 Anti-il-17f antibodies and methods of use thereof
03/14/2012EP2129359B1 Chimeric peptide antagonist for gpcr135 or gpcr142
03/14/2012EP2089546B1 Methods of diagnosing osteoarthritis
03/14/2012EP1962959B1 Neuropeptide-2 receptor-agonists
03/14/2012EP1910837B1 Methods and compositions for diagnosis and treatment of influenza
03/14/2012EP1633384B1 Stable analogs of glp-1
03/14/2012EP1622939B1 Active variants of the il-18 binding protein and medical uses thereof
03/14/2012EP1590447B1 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots
03/14/2012EP1546194B1 Therapeutic uspa1-derived peptides
03/14/2012EP1519743B1 Use of an interleukin 1 receptor antagonist alone or in combination with pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
03/14/2012EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use
03/14/2012EP1448984B1 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens
03/14/2012EP1436003B3 Taci-immunoglobulin fusion proteins
03/14/2012CN1558774B Angiotensin peptide-carrier conjugates and uses thereof
03/14/2012CN102378765A Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
03/14/2012CN102375062A Detection method of lactobacillus micro integral membrane protein active fragments
03/14/2012CN102373226A Methods for cloning, expressing and protein purifying of mutant HPV16 E7 (Human Papilloma Virus 16 Early Protein 7)
03/14/2012CN102373225A Recombinant protein A efficiently combined with IgG (Immunoglobulin G) and construction method of engineering bacterium thereof
03/14/2012CN102373224A Auxin transport protein gene of paddy rice and application thereof
03/14/2012CN102373223A Nucleotide sequence of LEA3 (Late Embryogenesis Abundant 3) protein coding gene from drought-resistant H.vulgare ssp.vulgare and application thereof
03/14/2012CN102373222A RAV-1 transcription factor from Huyou No.15, its preparation method and its application
03/14/2012CN102373221A RAV-2 transcription factor from Brassica napus L., its preparation method and application
03/14/2012CN102373220A Leymus chinensis saline alkali stress induced 14-3-3 protein gene
03/14/2012CN102373219A Salinity and alkalinity stress-induced aquaporin PIP gene of Leymus chinensis
03/14/2012CN102373218A Nucleic acid sequence coding Momordica charantia polypeptide P
03/14/2012CN102373217A Paddy DREBs (dehydration-responsive element binding) transcription factor and application thereof
03/14/2012CN102373216A Construction of recombinant eukaryotic hansenula engineering bacterial strains containing medical hirudin genes and production process of recombinant hirudin
03/14/2012CN102373196A Method for ultrahigh-level and targeting expression of salmon calcitonin protein in oleosin of transgenic rape by using chromosome substitution technology
03/14/2012CN102373179A (Blue Parvovirus)-TA isolated strain, standard sample of virus VP1, VP2 and NS1 genes complete sequences and preparation method thereof
03/14/2012CN102373171A Nucleoside antibiotic A201A superior strain and construction method thereof
03/14/2012CN102372777A Method for purifying natural serine protease inhibitors
03/14/2012CN102372776A Synthesis method of II pyrethroid artificial antigen
03/14/2012CN102372775A Method for producing conjugate of thyroxine and albumin
03/14/2012CN102372774A Synthesis method for atrazine artificial complete antigen
03/14/2012CN102372773A Human bladder cancer tumor marker, antibody thereof and application thereof
03/14/2012CN102372772A Ruditapes philippin RpTNF gene recombinant protein, its preparation and application
03/14/2012CN102372771A Tumor targeted molecule and application thereof
03/14/2012CN102372770A Angiogenesis inhibitant, purification method and medicinal composition therewith
03/14/2012CN102372769A Artemisia apiacea bHLH transcription factor as well as encoding gene and application thereof
03/14/2012CN102372768A Soybean phosphorus transportprotein GmPHT15 and application thereof
03/14/2012CN102372767A Plant trait related protein, coding gene and application thereof
03/14/2012CN102372766A O-type foot-and-mouth disease multi-epitope vaccine with cross immunity protective efficiency
03/14/2012CN102372737A Preparation method and application of parathion-methyl artificial hapten, artificial antigen and specific antibody
03/14/2012CN101974540B Application of Xanthomonas oryzae pv. oryzicola HapGxooc gene segment hpaG28-126
03/14/2012CN101845085B Wild soybean AP1 type protein and coding gene and application thereof
03/14/2012CN101712718B Protein relevant to plant drought resistance, coding gene and application thereof
03/14/2012CN101704881B Plant male fertility-associated protein, coding gene and application thereof
03/14/2012CN101486757B Plant chloroplast development associated protein, and coding gene and use thereof
03/14/2012CN101289506B Novel scavenger receptors
03/13/2012US8134045 Protein involved in restoration of cytoplasmic male sterility to fertility and gene encoding the protein and gene
03/13/2012US8133981 Therapeutic use of anti-CS1 antibodies
03/13/2012US8133980 Antibodies and functional fragments thereof that specifically bind an RF-amide peptide or a precursor thereof
03/13/2012US8133976 Methods of use of the TACI/TACI-L interaction
03/13/2012US8133974 Ferroportin1 nucleic acids, proteins, antibodies and methods
03/13/2012US8133973 Immunogenic compositions for Chlamydia trachomatis
03/13/2012US8133972 IgE antigenic peptides
03/13/2012US8133877 Composition comprising an antisense sequence implicated in the regulation of angiogenesis
03/13/2012US8133873 Recombinant chemokine-antigen vaccine
03/13/2012US8133866 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
03/13/2012US8133865 Two polymer chains (especially polyethylene oxide) connected to each other through a fluorenedicarbamoylmethyl group, which in turn is connected to an amine active agent by a releasable carbamate linkage; increased in vivo half-life
03/13/2012US8133862 Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency
03/13/2012US8133858 AXMI-008, a delta-endotoxin gene and methods for its use
03/13/2012US8133733 Nonviral vectors for delivering polynucleotides to target tissues
03/13/2012US8133724 Human androgen receptor alternative splice variants as biomarkers and therapeutic targets
03/13/2012US8133714 Process for the fermentative preparation of organic chemical compounds using coryneform bacteria in which the SugR gene is present in attenuated form
03/13/2012US8133700 Latent phase viral interleukin-10-(VII-10) and uses thereof
03/13/2012US8133699 Minimal DNA sequence acting as a chromatin insulator and its use in protein expression
03/13/2012US8133697 Methods of cleaving DNA with rationally-designed meganucleases
03/13/2012US8133689 Members of the capsaicin/vanilloid receptor family of proteins and uses thereof
03/13/2012US8133505 Transdermal delivery system for dried particulate or lyophilized medications
03/13/2012US8133498 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections
03/13/2012US8133494 Expression cassettes endcoding HIV-1 south african subtype C modified ENV proteins with deletions in V1 and V2
03/13/2012US8133490 Method and system to remove cytokine inhibitors in patients
03/13/2012US8133487 Soluble heterodimeric cytokine receptor
03/13/2012US8133486 Method and composition for altering a B cell mediated pathology
03/13/2012US8133480 Cysteine variants of interleukin-11
03/13/2012CA2567254C Tc-83-derived alphavirus vectors, particles and methods
03/13/2012CA2517452C Methods of detecting neurological disorders
03/13/2012CA2505942C West nile virus vaccine
03/13/2012CA2503130C Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens
03/13/2012CA2489227C Hla-a24-restricted cancer antigen peptides
03/13/2012CA2474216C Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
03/13/2012CA2459811C Modified peptides and their use for the treatment of autoimmune diseases
03/13/2012CA2419607C Peptidomimetic protease inhibitors
03/13/2012CA2402191C Use of insulin for the treatment of cartilagenous disorders
03/13/2012CA2388709C Gene upregulated in cancers of the prostate
03/13/2012CA2365898C Ibd-associated microbial antigens and methods of using same
03/13/2012CA2356779C Cytokine receptor chain
03/13/2012CA2347649C Mn gene and protein
03/13/2012CA2328140C Method of inhibiting osteoclast activity
03/13/2012CA2296272C Mammalian cytokine: interleukin-b30 and related reagents
03/13/2012CA2256308C Antibodies to the ed-b domain of fibronectin, their construction and uses
03/13/2012CA2238080C A novel haemopoietin receptor and genetic sequences encoding same
03/13/2012CA2216130C Process for the purification of glycoproteins like erythropoietin
03/13/2012CA2208524C Delivery of nucleic acid molecules to mucosal tissue
03/13/2012CA2199049C Novel pesticidal proteins and strains
1 ... 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 ... 2916